Get started

NVAX

Novavax Analysis 23.09.2021Hello Traders, welcome to this free and educational analysis. I am going to explain where I think this asset is going to go over the next days/weeks and where I would look for trading opportunities. If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below. I would also appreciate, if you would smash that like button and help me to create more free analysis like that. Thank you for watching and I will see you tomorrow!
NASDAQ:NVAX
by basictradingtv
TLMD - CHANNEL BOTTOM + FALLING WEDGE = BOOM GOES THE DYNAMITEAll, This is a crazy crazy setup. WW here for sure. Needs to hold this bottom. Easily worth taking a long here stop loss or not. Id probably not take a stop loss because sooooo many times it dips below all time low and support bottom falls 5-10% then moons. Happens literally all the time. I know not a high volume stock, but if this is right you can long hold for at least 20-40% gain if not more. MUST hold support and/or small dip under otherwise invalidated. HOWEVER following the falling wedge fails as well dips down and STILL in the falling wedge is fine just follow the # of attempts hitting falling wedge wall afte 3 rejections should be end of that. So either way this setup will blow up soon or easy to follow after.
TLong
by DigitalData
Earnings Week (08/02-08/06): Move Predictions, IV CrushBelow I've posted a compiled spreadsheet (Google Drive spreadsheet), outlining a large portion of upcoming earning releases for the week of August 2 through August 6, 2021. Options market overestimation percentages, predicted/actual earnings release moves, and average implied volatility (IV) numbers have all been sourced from Market Chameleon ( marketchameleon.com ). Google Drive spreadsheet public link: docs.google.com If and where I've posted quarterly analyst revision numbers, that data has been sourced from Seeking Alpha ( seekingalpha.com ). PLEASE take any analyst "recommendations" with a literal kilogram of salt, as any/all critical thinkers have noted a tendency toward foul play with "analyst" target numbers and recommendations (hint, they do not have YOUR best interests in mind). Current prices are obviously as of market close, Friday, 07/30/2021. The most important data provided lie in the first five columns immediately proceeding "Current Price." This spreadsheet provides a readily accessible, macro view of potential earnings plays for the week. I often use this overview to aid with decisions to either buy or write put/call spreads, credit/debit iron condors, or more standard long plays with protective puts, dependent upon overall market volatility (VIX), and equity-specific IV. Please post any comments/questions/concerns, and best of luck this busy week traders. NASDAQ:NXPI RIG SPG NYSE:BABA NYSE:BP COP UA LLY CLX ATVI OXY AYX CPE CVS SMG CLVS MPC ROKU UBER ETSY FSLY MPC WDC WYNN QRVO MRNA FVRR W REGN SQ NET ZG NVAX DKNG CGC GT NASDAQ:CRON
NYSE:BABA
by JRSone
4
In search for the next BNTX, MRNA and NVAX !!Since Covid-19 is here to stay with us with its variants and the vaccines don`t offer lifetime protection, this means that there is room for other companies to develop a better vaccine to address the problem. And the gains in vaccines stock are quite similar to cryptocurrencies year over year. From all time low to all time high, BNTX made 19X, MRNA 24X and NVAX 66X. My question for you is the following: which is the next vaccine developer to make at least 10X our money?? I`m looking forward to discover with you the next big vaccine developer! And i have a presumption or two which i already shared in my group. And those were the fundamentals i was searching for: data submitted to FDA for Emergency Use Authorization, Phase 3, low Market cap - under 1Bil, on the lower end of 52 Week Range, other drugs in the pipeline, high intraday volume.
NASDAQ:BNTXLong
by TopgOptions
18
NVAX Novavax Analyst RatingsOn 6/15/2021 Cantor Fitzgerald brokerage Boosted the Price Target from Reduce to Overweight $217.00 to $272.00 On 5/18/2021 JPMorgan Chase & Co. brokerage Reiterated Rating from Overweight to Neutral $285.00 to $161.00 On 5/12/2021 B. Riley brokerage Lowered the Price Target from $365.00 to $286.00 On 5/12/2021 HC Wainwright brokerage Lowered the Price Target from $317.00 to $294.00 My personal price target is $240. Looking forward to read your opinion.
NASDAQ:NVAXLong
by TopgOptions
NVAX to attack down trend line again, Watch carefully !NVAX is going to attack the down trend line once more after a short recovery and regaining some energy. Who wins the battle? lets follow and see. NVAX has reacted well to very strong support formed by 0.618 Retracement of last major rally and 0.786 projection of possible wave A of an ABC form of correction. This is shown on the chart. It is worth to note that chart is in logarithmic scale. I, myself think that NVAX is not able to break the line this time and it needs one more attack later. But who knows? Please take into consideration that : Market never follows our predictions , We are the one who should follow the market. Good luck my friends
NASDAQ:NVAX
by SaeedSajedi
5
$AAPL $AMZN $NVAX $GLD I OptionsSwing WatchlistAMZN 1D I As AMZN earnings approach on 07/29, we are seeing AMZN about to retest ATH levels, expecting a breakout. AAPL 1D I After the breakout from our triangle AAPL running non-stop to retest ATH levels, earnings on 07/27 will decide where it goes. GLD 1D I After breaking out from a bull flag back, we are seeing GLD retrace back and possibly making a double bottom near $165. NVAX 4H I Is breaking out from a downtrend with volume, we are expecting to see a run up into its earnings on 08/09.
NASDAQ:AMZN
by optionsswing
Are we close to observe a breakout on NVAX ?Novavax COVID-19 vaccine more than 90% effective in U.S trial according to Reuters. Despite positive news (which we do not trade), we will share with you our current view on Novavax. a) The price is inside a descending Wedge, and due to positive news, we are observing a bullish GAP, and we may see the price outside the Wedge pattern b) The general strategy we will use to develop bullish setups on the pharmaceutical company is waiting for the price to reach 250 - 270 and then an ABC corrective pattern, as you can see on the chart. c) IF that scenario happens, we will trade above B, and our stop loss will be set below C d) Regarding the targets, we will be using the Fibo Extensions of the major descending wedge Thanks for reading!
NASDAQ:NVAXLong
by ThinkingAntsOk
5